Volume | 110,120 |
|
|||||
News | - | ||||||
Day High | 0.032 | Low High |
|||||
Day Low | 0.0288 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Elite Pharmaceuticals Inc (QB) | ELTP | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.032 | 0.0288 | 0.032 | 0.032 | 0.0315 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
29 | 110,120 | $ 0.030133 | $ 3,318 | - | 0.0268 - 0.052 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:42:06 | 2,700 | $ 0.032 | USD |
Elite Pharmaceuticals Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 32.45M | 1.01B | 715.12M | $ - | $ - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
2.01k | $ - | - | - | - |
Elite Pharmaceuticals (QB) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELTP Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0291 | 0.032 | 0.02865 | 0.0301822 | 185,493 | 0.0029 | 9.97% |
1 Month | 0.0395 | 0.0395 | 0.02865 | 0.0325208 | 392,586 | -0.0075 | -18.99% |
3 Months | 0.0291 | 0.04 | 0.0269 | 0.0330694 | 358,389 | 0.0029 | 9.97% |
6 Months | 0.0378 | 0.04 | 0.0269 | 0.0331228 | 340,006 | -0.0058 | -15.34% |
1 Year | 0.03575 | 0.052 | 0.0268 | 0.0376854 | 384,315 | -0.00375 | -10.49% |
3 Years | 0.055 | 0.10 | 0.023 | 0.0541764 | 748,057 | -0.023 | -41.82% |
5 Years | 0.1035 | 0.141 | 0.023 | 0.0678499 | 753,138 | -0.0715 | -69.08% |
Elite Pharmaceuticals (QB) Description
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. |